2Fine NU, Singer DE. Phelps AL. Hanusa BH, Kapoor WN. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospecbve fcur-hospltal study. Med Care. 1993;31:371-380.
3Gilbert K, Gleason PP, Singer DE, et al. Variations in antimicroblal use and cost in more than 2,000 patients with community-acquired pneumonia. Am J.Med. 1998;104:17-27.
4Weingarten SR, Riedinger MS. Hobson P, et al.Evaluation of a pneumonia practice guideline in an interventional trial. Am J Respir Crit Care Med. 1996;5.
5Fine MI, Smith MA. Carson CA. et al. Prngnosts and outcomes Of patierts with community-acquired pneumonia: a meta-analysis. JAMA. 1996;275:134-141.
6Niedenman MS, McCombs J, Unger A, Kumar A,Popovian R. The cost of treating community-acquired pneumonia. Clin Ther. 1998;20:820-836.
7Ellrodt G Cook D J, Lee J, et al. Evidence -based disease management. JAMA. 1997;278:1687-1692.
8Welngarten SR, Riedinger MS, Varis G, et al. Identitication of low-risk hospitalized patients with peumonia. Chest. 1994.;105:1109-1115
9Pearson SO, Lee TH. Goldhaber S;Z. A critical pathway to beat proximal lower-extremlty deep veir thtombosis. Am J Med. 1996;100:283-289.
10Raschke RA, Reilly BM, Guldly JR Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram Ann Intern Med. 1993;119:874-881.
